Sharon Longhurst
Direktor/Vorstandsmitglied bei IDOGEN AB (PUBL)
Aktive Positionen von Sharon Longhurst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IDOGEN AB (PUBL) | Direktor/Vorstandsmitglied | 12.05.2020 | - |
| Independent Dir/Board Member | 12.05.2020 | - | |
| ELICERA THERAPEUTICS AB | Direktor/Vorstandsmitglied | 01.01.2024 | - |
| Independent Dir/Board Member | 01.01.2024 | - |
Karriereverlauf von Sharon Longhurst
Ehemalige bekannte Positionen von Sharon Longhurst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 01.10.2021 | 01.08.2023 |
| MENDUS AB | Corporate Officer/Principal | - | - |
Ausbildung von Sharon Longhurst
| University of Warwick | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Statistik
International
| Schweden | 4 |
| Vereinigtes Königreich | 3 |
| Niederlande | 2 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MENDUS AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
- Börse
- Insiders
- Sharon Longhurst
- Erfahrung
